4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 YearsDNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted diseaseRecruitingPhase 32026-01-16NCT05262010
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)Respiratory Syncytial Virus (RSV)RecruitingPhase 32025-12-09NCT07272434
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineActinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanusRecruitingPhase 12024-01-03NCT06184542
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 YearsDNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 32023-09-18NCT06041061